Articles tagged with 'Congress' | BIOTRONIK

BIOTRONIK - Archive (Congress)

2019
07
June
2019
| 00:00 Europe/Amsterdam
New data from the BIOSOLVE-IV registry strengthen the clinical evidence for the Magmaris®1 resorbable scaffold device and procedure success and safety profile at one year. Dr. Stefan Verheye, Senior Interventional Cardiologist at Antwerp Cardiovascul...
Read more
21
May
2019
| 00:00 Europe/Amsterdam
Focusing on patients with small vessels, three-year outcomes of the BIO-RESORT randomized controlled trial (RCT) showed a significantly lower target lesion revascularization (TLR) rate and thus better efficacy of the Orsiro® drug-eluting stent1 (DES)...
Read more
08
May
2019
| 00:00 Europe/Amsterdam
Heartbeat International (HBI) Foundation President Dr. Benedict S. Maniscalco will be honored with the Heart Rhythm Society (HRS) Global Humanitarian Award at this year’s Scientific Sessions. Dr. Maniscalco, the first-ever recipient of this award, is...
Read more
2018
20
November
2018
| 00:00 Europe/Amsterdam
Following a statistical calculation error, the outcomes of SORT-OUT IX1 have recently been corrected, resulting in a change to the trial’s primary endpoint. The revised data analysis demonstrates that compared to BIOTRONIK’s Orsiroa drug-eluting sten...
Read more
24
September
2018
| 00:00 Europe/Amsterdam
Today, BIOTRONIK announced two-year data from the BIOFLOW-V randomized trial comparing the Orsiro and Xience1 drug-eluting stents (DES). The data shows statistically improved outcomes for patients treated with Orsiro across a range of clinical endpoi...
Read more